Literature DB >> 18560953

[Treatment of salivary gland malignancies].

Michael Formanek1.   

Abstract

Salivary gland carcinomas comprise a rare group of malignant tumors which are characterized by their histopathological diversity, variable clinical course, in particular with respect to the facial nerve. Surgical resection with or without adjuvant radiotherapy is the treatment of choice. Surgical procedures are depending on the pathohistological diagnosis and the clinical staging according to the TNM classification respectively. The present paper gives a short overview about the therapeutic modalities with malignant tumors of the salivary glands.

Entities:  

Mesh:

Year:  2008        PMID: 18560953     DOI: 10.1007/s10354-008-0532-0

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  11 in total

Review 1.  Neck dissection in the treatment of cancer of major salivary glands.

Authors:  J E Medina
Journal:  Otolaryngol Clin North Am       Date:  1998-10       Impact factor: 3.346

2.  Treatment of carcinoma of the parotid gland: the results of a multicenter study.

Authors:  A Tullio; C Marchetti; E Sesenna; R Brusati; R Cocchi; V Eusebi
Journal:  J Oral Maxillofac Surg       Date:  2001-03       Impact factor: 1.895

3.  Clinical prognostic factors in malignant parotid gland tumors.

Authors:  Roberto A Lima; Marcos R Tavares; Fernando L Dias; Jacob Kligerman; Marilene F Nascimento; Mauro M Barbosa; Claudio R Cernea; Jose R Soares; Izabella C Santos; Scheylla Salviano
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

Review 4.  [Salivary gland carcinomas Part II. Diagnosis and therapy].

Authors:  S Lang; N Rotter; A Lorenzen; S Ihrler; R Eckel; D Hölzel; G Rasp; B Wollenberg; K Sommer
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

Review 5.  TNM staging of cancers of the head and neck: striving for uniformity among diversity.

Authors:  Snehal G Patel; Jatin P Shah
Journal:  CA Cancer J Clin       Date:  2005 Jul-Aug       Impact factor: 508.702

6.  Elective neck dissection versus observation in primary parotid carcinoma.

Authors:  P Zbären; J Schüpbach; M Nuyens; E Stauffer
Journal:  Otolaryngol Head Neck Surg       Date:  2005-03       Impact factor: 3.497

7.  Carcinoma of the parotid gland.

Authors:  Peter Zbären; Jonas Schüpbach; Michel Nuyens; Edouard Stauffer; Richard Greiner; Rudolf Häusler
Journal:  Am J Surg       Date:  2003-07       Impact factor: 2.565

Review 8.  Tumors of the submandibular gland: clinicopathologic analysis of 23 patients.

Authors:  Alexander D Rapidis; Spyros Stavrianos; George Lagogiannis; Gregory Faratzis
Journal:  J Oral Maxillofac Surg       Date:  2004-10       Impact factor: 1.895

9.  The indications for elective treatment of the neck in cancer of the major salivary glands.

Authors:  J G Armstrong; L B Harrison; H T Thaler; H Friedlander-Klar; D E Fass; M J Zelefsky; J P Shah; E W Strong; R H Spiro
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

10.  Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function.

Authors:  Orlando Guntinas-Lichius; Jens Peter Klussmann; Ulla Schroeder; Gero Quante; Markus Jungehuelsing; Eberhard Stennert
Journal:  Laryngoscope       Date:  2004-05       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.